---
$id: https://graph.org.ai/products/commodity/51141572
$type: Product
source: UNSPSC
code: "51141572"
title: "Pivagabine"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pivagabine

**UNSPSC Code**: 51141572
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C9H17NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C53SV0WO4V, chemically known as 4-((2,2-dimethylpropionyl)amino)butyric acid but generally known as pivagabine, which bears US NIH Compound Identifier 68888. European Medicines Agency schedules Pivagabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09948MIG. The term PIVAGABINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). World Health Organization schedules pivagabine in its Anatomical Therapeutic Chemical (ATC) Classification. PIVAGABINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pivagabine under HS 29241900 and SITC 51471. As of Q4 2014, PIVAGABINE remains the US FDA Preferred Term for this commodity. Pivagabine bears US NLM identifiers UMLS ID C0619323 and NCI Concept Code C66440. SMILES: O=C(NCCCC(=O)O)C(C)(C)C.

